Why Vera Therapeutics Stock Zoomed Higher Today
The company has a fine chance of commercializing its leading investigational drug in the near future.One of the happiest moments an investor in the biotech sector can have is when one of his or her companies reports a regulatory submission for a promising product. Sure enough, investors snapped up shares of Vera Therapeutics (VERA +4.64%) on Wednesday, sending them to a nearly 5% gain, on the company's news that it made such a filing. FDA decision coming soonThat morning, Vera announced that its biologics l ...